spacer
home > ict > spring 2018 > improving success rates
PUBLICATIONS
International Clinical Trials

Improving Success Rates

Innovative methodologies are paving the way to a better outlook for Alzheimer’s clinical trials. Improvements in understanding of pathophysiological mechanisms, innovative clinical trial design, and better operational oversight are addressing well-documented research challenges associated with this complex, multifaceted disease.

Daunting failure rates – reaching 99.6% – have historically plagued advancement of new treatments and potential cures for the 28-37 million people impacted (1,2). However, new insights are helping investigators address a continuing source of problematic research: patient recruitment.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Michael F Murphy’s professional career has spanned 25 years and his positions within the pharma industry emphasise the integration of medical and scientific acumen with operational excellence. He is board-certified in psychiatry and has a doctorate in pharmacology, with training at Tulane University, Stanford University, and the Mt Sinai School of Medicine, US. Michael worked with Dr Cutler in articulating this vision for Worldwide Clinical Trials when the company was established as a global CRO in 1995. His supervisory responsibilities as Chief Medical and Scientific Officer at Worldwide are international in scope.
spacer
Dr Michael F Murphy
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

c-LEcta signs Europe sales and distribution agreement with VWR for c-LEcta’s DENARASE®

• DENARASE® is now available through VWR’s sales channels in Europe • VWR, part of Avantor, is a leading global provider of product and service solutions to laboratory and production customers • Cooperation harbors the potential for c-LEcta’s product to gain additional share in a highly dynamic market
More info >>

White Papers

Key to Outsourcing Method Development and Validation A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developer’s mind set and a regulatory background in validation.
More info >>

 
Industry Events

Synthetic Biology Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its Synthetic Biology Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement